Search results for "diabetes mellitu"

showing 10 items of 2088 documents

Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders

2019

Thyroid dysfunction and diabetes mellitus are closely linked. Several studies have documented the increased prevalence of thyroid disorders in patients with diabetes mellitus and vice versa. This review critically discusses the different underlying mechanisms linking type 1 and 2 diabetes and thyroid dysfunction to demonstrate that the association of these two common disorders is unlikely a simple coincidence. We assess the current state of knowledge on the central and peripheral control of thyroid hormone on food intake and glucose and lipid metabolism in target tissues (such as liver, white and brown adipose tissue, pancreatic b cells, and skeletal muscle) to explain the mechanism linking…

0301 basic medicineendocrine system diseasesEndocrinology Diabetes and MetabolismReviews030209 endocrinology & metabolismType 2 diabetesBioinformatics03 medical and health sciences0302 clinical medicineEndocrinologyHypothyroidismDiabetes mellitusmedicineAnimalsHumansSubclinical infectionType 1 diabetesbusiness.industryThyroidmedicine.diseaseThyroid DiseasesDiabetes Mellitus Type 1030104 developmental biologymedicine.anatomical_structureDiabetes Mellitus Type 2Metabolic control analysisMetabolic syndromeHyperthyroidism Hypothyroidism type 1 diabetes mellitus type 2 diabetes mellitus metabolic syndrome pregnancy guidelinesbusinessHormoneEndocrine Reviews
researchProduct

Mitochondria, the NLRP3 Inflammasome, and Sirtuins in Type 2 Diabetes: New Therapeutic TargetsReviewing Editors:Markus Bachschmid, Dylan Burger, Vitt…

2018

Abstract Significance: Type 2 diabetes mellitus and hyperglycemia can lead to the development of comorbidities such as atherosclerosis and microvascular/macrovascular complications. Both type 2 dia...

0301 basic medicineendocrine system diseasesPhysiologyClinical BiochemistryType 2 diabetesMitochondrionBioinformaticsmedicine.disease_causeBiochemistry03 medical and health sciencesMedicineMolecular BiologyGeneral Environmental Sciencebusiness.industryfungifood and beveragesnutritional and metabolic diseasesType 2 Diabetes MellitusInflammasomeCell Biologymedicine.disease030104 developmental biologyGeneral Earth and Planetary SciencesbusinessOxidative stressmedicine.drugAntioxidants & Redox Signaling
researchProduct

Celiac disease and endocrine autoimmunity - the genetic link.

2018

Celiac disease is a small intestinal inflammatory disease with autoimmune features that is triggered and maintained by the ingestion of the storage proteins (gluten) of wheat, barley and rye. The prevalence of celiac disease is increased in patients with monoglandular and/or polyglandular autoimmunity and their relatives. Between 10 and 30% of patients with celiac disease are thyroid and/or type 1 diabetes antibody positive, while around 5 to 7% of patients with autoimmune thyroid disease and/or type 1 diabetes are IgA anti-tissue transglutaminase antibody positive. The close relationship between celiac disease and endocrine autoimmunity is largely explained by sharing a common genetic back…

0301 basic medicineendocrine system diseasesTissue transglutaminaseImmunology030209 endocrinology & metabolismAutoimmunityDiseaseHuman leukocyte antigenmedicine.disease_causePolymorphism Single NucleotideAutoimmunityAutoimmune Diseases03 medical and health sciences0302 clinical medicineHLA AntigensGenetic predispositionImmunology and AllergyMedicineHumansGenetic Predisposition to DiseaseType 1 diabetesbiologybusiness.industryThyroidnutritional and metabolic diseasesmedicine.diseasedigestive system diseasesCeliac Disease030104 developmental biologymedicine.anatomical_structureDiabetes Mellitus Type 1Immunologybiology.proteinGluten freebusinessAutoimmunity reviews
researchProduct

Type 1 diabetes associated autoimmunity.

2016

Diabetes mellitus is increasing in prevalence worldwide. The economic costs are considerable given the cardiovascular complications and co-morbidities that it may entail. Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the loss of insulin-producing pancreatic β-cells. The pathogenesis of T1D is complex and multifactorial and involves a genetic susceptibility that predisposes to abnormal immune responses in the presence of ill-defined environmental insults to the pancreatic islets. Genetic background may affect the risk for autoimmune disease and patients with T1D exhibit an increased risk of other autoimmune disorders such as autoimmune thyroid disease, Addison's dise…

0301 basic medicineendocrine systemendocrine system diseasesAutoimmune GastritisImmunology030209 endocrinology & metabolismAutoimmunityVitiligoDiseasemedicine.disease_causeCoeliac diseaseAutoimmunity03 medical and health sciencesIslets of LangerhansMice0302 clinical medicineImmunology and AllergyMedicineAnimalsHumansGenetic Predisposition to Diseasepernicious anemiaAutoimmune diseaseType 1 diabetesbusiness.industrymedicine.disease030104 developmental biologyDiabetes Mellitus Type 1Organ SpecificityImmunologybusinessAutoimmunity reviews
researchProduct

Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors

2020

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dipeptidyl peptidase-4 (DPP-4) inhibitors are so called “incretin-based therapies” (IBTs) that represent innovative therapeutic approaches and are commonly used in clinical practice for the treatment of type 2 diabetes mellitus (T2DM). The cardiovascular outcome trials (CVOTs) have provided useful information that has helped to shape changes in clinical practice guidelines for the management of T2DM. At the same time, the mechanisms that may explain the nonglycemic and cardiovascular (CV) benefits of these medications are still being explored. A summary of the main findings from CVOTs performed to-date with particular emphasis on vari…

0301 basic medicineendocrine systemmedicine.medical_specialtyDipeptidyl Peptidase 4Endocrinology Diabetes and MetabolismIncretin030209 endocrinology & metabolismClass effectBody weightCardiovascular SystemIncretinsGlucagon-Like Peptide-1 Receptor03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineType 2 diabetes mellitusmedicineAnimalsHumansIntensive care medicineGlucagon-like peptide 1 receptorDipeptidyl-Peptidase IV Inhibitorsbusiness.industryDPP-4 Inhibitorsdigestive oral and skin physiologyType 2 Diabetes MellitusCardiovascular riskDPP4- inhibitorClinical Practice030104 developmental biologyCardiovascular DiseasesGlucagon-like peptide 1 receptor agonistbusinessCardiovascular outcomesMetabolism
researchProduct

Arsenic exposure, diabetes-related genes and diabetes prevalence in a general population from Spain.

2018

Inorganic arsenic exposure may be associated with diabetes, but the evidence at low-moderate levels is not sufficient. Polymorphisms in diabetes-related genes have been involved in diabetes risk. We evaluated the association of inorganic arsenic exposure on diabetes in the Hortega Study, a representative sample of a general population from Valladolid, Spain. Total urine arsenic was measured in 1,451 adults. Urine arsenic speciation was available in 295 randomly selected participants. To account for the confounding introduced by non-toxic seafood arsenicals, we designed a multiple imputation model to predict the missing arsenobetaine levels. The prevalence of diabetes was 8.3%. The geometric…

0301 basic medicineinorganic chemicalsAdultMaleRiskDiabetes riskHealth Toxicology and MutagenesisPopulationPhysiologychemistry.chemical_elementUrine010501 environmental sciencesToxicology01 natural sciencesArsenicalsArticleArsenic03 medical and health scienceschemistry.chemical_compoundYoung AdultDiabetes mellitusDiabetes MellitusOdds RatioPrevalenceMedicineHumanseducationArsenic0105 earth and related environmental scienceseducation.field_of_studyintegumentary systembusiness.industryConfoundingGeneral MedicineOdds ratioEnvironmental ExposureMiddle Agedmedicine.diseasePollution030104 developmental biologychemistrySeafoodSpainEnvironmental PollutantsFemaleArsenobetainebusinessEnvironmental pollution (Barking, Essex : 1987)
researchProduct

Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes

2019

Visual Abstract

0301 basic medicinelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyCardiac & Cardiovascular Systemsempagliflozinheart failure030204 cardiovascular system & hematologySGLT2i sodium-glucose co-transporter 2 inhibitorHF heart failurePRECLINICAL RESEARCH03 medical and health sciences0302 clinical medicineDM diabetes mellitusDiabetes mellitusInternal medicinemedicineEmpagliflozinMI-HF post-infarct heart failureGlycemicScience & TechnologyEjection fractionbusiness.industryNHE sodium-hydrogen exchangerANN artificial neural networkmedicine.diseaseHFrEF HF with reduced ejection fractionBlockadeXIAPmachine learning030104 developmental biologyMechanism of actionlcsh:RC666-701Heart failureCardiovascular System & CardiologyCardiologyRNAseq RNA sequencingempagtiflozinmedicine.symptomCardiology and Cardiovascular MedicinebusinessLife Sciences & BiomedicineJACC: Basic to Translational Science
researchProduct

Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.

2019

The Collaborative Working Group “Noma Project Team”.

0301 basic medicinelcsh:Immunologic diseases. Allergycritical limb ischemiaCell typecost-effectivecell-based therapyImmunologyBioinformaticsCell therapy03 medical and health sciences0302 clinical medicineImmunology and AllergyMedicineOriginal Researchclinical trialsdiabetesbusiness.industryMesenchymal stem cellType 2 Diabetes MellitusCritical limb ischemiacellular medicamentsClinical trial030104 developmental biologyStem cellmedicine.symptombusinesslcsh:RC581-607030215 immunologyAdult stem cell
researchProduct

Significance of magnesium in insulin resistance, metabolic syndrome, and diabetes – recommendations of the Association of Magnesium Research e.V.

2017

Magnesium (Mg) depletion is an important and highly prevalent condition in patients with diabetes or precursor states of type-2 diabetes like metabolic syndrome. Mg deficiency increases the risk of developing type-2 diabetes. These recommendations compile present data on the physiology of Mg in carbohydrate metabolism and pathophysiological consequences of Mg depletion for diabetics. Diabetes patients and candidates benefit from four categories of Mg effects: insulin-sensitizing effect, calcium antagonism, stress-regulating and endotheli-um-stabilizing effects. Clinical data with Mg co-medication show improvement of insulin resistance/blood glucose level and reduced long-term vascular damag…

0301 basic medicinemedicine.medical_specialty030109 nutrition & dieteticsbusiness.industryMagnesiumInsulinmedicine.medical_treatmentClinical Biochemistrymagnesium insulin diabeteschemistry.chemical_elementmedicine.diseaseBiochemistryInorganic Chemistry03 medical and health sciencesEndocrinologyInsulin resistancechemistryDiabetes mellitusInternal medicineMedicineMetabolic syndromebusinessTrace Elements and Electrolytes
researchProduct

Coffee and metabolic impairment: An updated review of epidemiological studies

2016

Abstract Background Coffee is one of the most consumed beverages worldwide. In the last years, coffee consumption has been associated with a number of beneficial effects against metabolic impairment. The aim of this narrative review was to report the most updated and comprehensive evidence from epidemiological and experimental studies as well as mechanisms of action of coffee on metabolic impairment. Methods A search in electronic databases (PUBMED and EMBASE) was performed to retrieve systematic and pooled analyses on coffee and diabetes, hypertension, and dyslipidemia. Furthermore, the most accredited hypotheses and mechanisms of action of coffee have been described. Results Coffee consum…

0301 basic medicinemedicine.medical_specialtyAntioxidantmedicine.medical_treatmentMetabolic disordersPhysiologyBlood lipidslcsh:TX341-641030209 endocrinology & metabolismDiabeteCoffee03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCaffeineDiabetes mellitusEpidemiologymedicineFood science030109 nutrition & dieteticsNutrition and Dieteticslcsh:TP368-456business.industryDiabetesMetabolic disordermedicine.diseaselcsh:Food processing and manufactureBlood pressurechemistryObservational studybusinessCaffeinelcsh:Nutrition. Foods and food supplyDyslipidemiaFood ScienceNFS Journal
researchProduct